ReNerve Limited (ASX:RNV)
Australia · Delayed Price · Currency is AUD 0.0800
+0.0010 (1.27%)
At close: Jul 9, 2026
ReNerve Market Cap
ReNerve has a market cap or net worth of 13.78 million as of July 14, 2026. Its market cap has decreased by -19.39% in one year.
Market Cap
13.78M
Enterprise Value
9.76M
Revenue
333.21K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since November 26, 2024, ReNerve's market cap has decreased from 26.95M to 13.78M, a decrease of -48.85%. That is a compound annual growth rate of -33.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 13.78M | -16.69% |
| Dec 31, 2025 | 16.55M | -33.34% |
| Dec 31, 2024 | 24.82M | -7.89% |
| Nov 26, 2024 | 26.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 26.12M |
| Algorae Pharmaceuticals | 25.32M |
| NeuroScientific Biopharmaceuticals | 23.61M |
| Neurotech International | 21.08M |
| EZZ Life Science Holdings | 20.47M |
| Argenica Therapeutics | 17.98M |
| Immuron | 14.05M |
| AdAlta | 11.90M |